ICHALIG

Welcome to the Brand page for “ICHALIG”, which is offered here for In the statement, line 2 through 4 should be deleted, and fl 5, blg a6, sci. ent. accelerator, 11 kaiyuan avenue, science city, guangzhou, guangdong, china 510535 should be inserted.;pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ICHALIG” is believed to be currently owned by “Bio-Thera Solutions, Ltd.”


Owner:
BIO-THERA SOLUTIONS, LTD.
Owner Details
Description:
In the statement, line 2 through 4 should be deleted, and Fl 5, Blg A6, Sci. Ent. Accelerator, 11 Kaiyuan Avenue, Science City, Guangzhou, Guangdong, China 510535 should be inserted.;Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases;Color is not claimed as a feature of the mark.;
Categories: STATEMENT